Menu Back toSession 2 : COVID-19 Treatment Development Experiences

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone


Session 2 : COVID-19 Treatment Development Experiences

Session Chair(s)

Jeewon  Joung, PhD

Jeewon Joung, PhD

  • Deputy Director
  • Korean Ministry of Food and Drug Safety (MFDS) , Korea, Republic of

Speaker(s)

Carisa Stadlman  De Anda

Carisa Stadlman De Anda

  • MSD, Korea, Republic of
Min Soo  Kim

Min Soo Kim

  • Director, Head of Cell Science Department, Research & Development
  • Celltrion, Korea, Republic of
Jin Yong   Kim, MD, MPH

Jin Yong Kim, MD, MPH

  • Physician, Div. of Infectious Diseases, Dept. of Internal Medicine
  • Incheon Medical Center, Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574